A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors
Clinical trial NCT05176509 · COMPLETED
Trial details
- NCT number
- NCT05176509
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2023-08-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.